Medicine prices: Senate body directs CCP to review hike

The Senate Standing Committee on National Health Services and Regulations on Thursday advanced on major health reforms and pharmaceutical deregulation strategies. The Senate body also directed the Competition Commission of Pakistan (CCP) to review the matter of the recent hike in medicine prices. The standing committee met here under the chairmanship of Senator Amir Waliuddin Chishti to deliberate on critical legislative amendments and sector-wide performance reviews aimed at modernizing Pakistan’s healthcare infrastructure and regulatory frameworks. It emphasized that while private investment is appreciated, it must not come out of the poor and general public’s money.